IL23R and acute lymphoblastic leukemia: The ability of IL‐23 to inhibit B‐ALL growth was studied both in vitro by treating primary B‐ALL cells with IL‐23 and in vivo using SCID/NOD mice injected with 697 cell line expressing IL‐23R.